Single-fraction HDR brachytherapy combined with SBRT for intermediate and high-risk prostate cancer: Oncologic and patient-reported outcomes from a prospective phase II study
- DOI
- 10.1016/j.radonc.2026.111639
- Published
- 2026-08
- Container
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.radonc.2026.111639,
title = {Single-fraction HDR brachytherapy combined with SBRT for intermediate and high-risk prostate cancer: Oncologic and patient-reported outcomes from a prospective phase II study},
author = {David Büchser and Laura Zaragoza and Itziar Valverde and Borja Santos-Zorrozua and Jose-Fernando Perez and Carlos Mascarell and Libe del Castillo and Ana Hompanera and Jose Maria Espinosa and Jon Cacicedo and Alfonso Gomez-Iturriaga},
year = {2026},
journal = {Radiotherapy and Oncology},
doi = {10.1016/j.radonc.2026.111639},
url = {https://doi.org/10.1016/j.radonc.2026.111639}
}RIS
TY - JOUR TI - Single-fraction HDR brachytherapy combined with SBRT for intermediate and high-risk prostate cancer: Oncologic and patient-reported outcomes from a prospective phase II study AU - David Büchser AU - Laura Zaragoza AU - Itziar Valverde AU - Borja Santos-Zorrozua AU - Jose-Fernando Perez AU - Carlos Mascarell AU - Libe del Castillo AU - Ana Hompanera AU - Jose Maria Espinosa AU - Jon Cacicedo AU - Alfonso Gomez-Iturriaga PY - 2026 JO - Radiotherapy and Oncology DO - 10.1016/j.radonc.2026.111639 UR - https://doi.org/10.1016/j.radonc.2026.111639 ER -
APA
Büchser, D., Zaragoza, L., Valverde, I., Santos-Zorrozua, B., Perez, J., Mascarell, C., Castillo, L. D., Hompanera, A., Espinosa, J. M., Cacicedo, J., & Gomez-Iturriaga, A. (2026). Single-fraction HDR brachytherapy combined with SBRT for intermediate and high-risk prostate cancer: Oncologic and patient-reported outcomes from a prospective phase II study. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2026.111639
Source records
- crossref · retrieved 2026-09-25T16:49:02.801Z